473 related articles for article (PubMed ID: 37790810)
1. A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy.
Riccardi F; Dal Bo M; Macor P; Toffoli G
Front Pharmacol; 2023; 14():1274088. PubMed ID: 37790810
[TBL] [Abstract][Full Text] [Related]
2. Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences.
Barreca M; Lang N; Tarantelli C; Spriano F; Barraja P; Bertoni F
Explor Target Antitumor Ther; 2022; 3(6):763-794. PubMed ID: 36654819
[TBL] [Abstract][Full Text] [Related]
3. Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate.
Sheyi R; de la Torre BG; Albericio F
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214128
[TBL] [Abstract][Full Text] [Related]
4. Antibody-Drug Conjugates-A Tutorial Review.
Baah S; Laws M; Rahman KM
Molecules; 2021 May; 26(10):. PubMed ID: 34063364
[TBL] [Abstract][Full Text] [Related]
5. Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.
Hong Y; Nam SM; Moon A
Arch Pharm Res; 2023 Mar; 46(3):131-148. PubMed ID: 36877356
[TBL] [Abstract][Full Text] [Related]
6. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)].
Tsuchikama K
Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230
[TBL] [Abstract][Full Text] [Related]
7. Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development.
Singh D; Dheer D; Samykutty A; Shankar R
J Control Release; 2021 Dec; 340():1-34. PubMed ID: 34673122
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload.
Kondrashov A; Sapkota S; Sharma A; Riano I; Kurzrock R; Adashek JJ
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631374
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability.
Nguyen TD; Bordeau BM; Balthasar JP
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765668
[TBL] [Abstract][Full Text] [Related]
10. Antibody-Drug Conjugates for Breast Cancer.
Marmé F
Oncol Res Treat; 2022; 45(1-2):26-36. PubMed ID: 34915488
[TBL] [Abstract][Full Text] [Related]
11. Antibody-Drug Conjugates as a Targeted Therapeutic Approach Across Entities in Oncology.
Lordick F; Merz M; Büch E; Aigner A
Dtsch Arztebl Int; 2023 May; 120(19):329-336. PubMed ID: 37073718
[TBL] [Abstract][Full Text] [Related]
12. Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives.
Sganga S; Riondino S; Iannantuono GM; Rosenfeld R; Roselli M; Torino F
J Pers Med; 2023 Aug; 13(9):. PubMed ID: 37763107
[TBL] [Abstract][Full Text] [Related]
13. The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively.
Li WQ; Guo HF; Li LY; Zhang YF; Cui JW
Cancer Med; 2021 Jul; 10(14):4677-4696. PubMed ID: 34165267
[TBL] [Abstract][Full Text] [Related]
14. Antibody-Drug Conjugates for Cancer Therapy.
Hafeez U; Parakh S; Gan HK; Scott AM
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081383
[TBL] [Abstract][Full Text] [Related]
15. Antibody drug conjugate: the "biological missile" for targeted cancer therapy.
Fu Z; Li S; Han S; Shi C; Zhang Y
Signal Transduct Target Ther; 2022 Mar; 7(1):93. PubMed ID: 35318309
[TBL] [Abstract][Full Text] [Related]
16. Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy.
Aggarwal D; Yang J; Salam MA; Sengupta S; Al-Amin MY; Mustafa S; Khan MA; Huang X; Pawar JS
Front Immunol; 2023; 14():1203073. PubMed ID: 37671162
[TBL] [Abstract][Full Text] [Related]
17. Novel development strategies and challenges for anti-Her2 antibody-drug conjugates.
Zhang X; Huang AC; Chen F; Chen H; Li L; Kong N; Luo W; Fang J
Antib Ther; 2022 Jan; 5(1):18-29. PubMed ID: 35146330
[TBL] [Abstract][Full Text] [Related]
18. Antibody-Drug Conjugate-Based Therapeutics: State of the Science.
Birrer MJ; Moore KN; Betella I; Bates RC
J Natl Cancer Inst; 2019 Jun; 111(6):538-549. PubMed ID: 30859213
[TBL] [Abstract][Full Text] [Related]
19. Antibody-Drug Conjugates Containing Payloads from Marine Origin.
Cheng-Sánchez I; Moya-Utrera F; Porras-Alcalá C; López-Romero JM; Sarabia F
Mar Drugs; 2022 Jul; 20(8):. PubMed ID: 36005497
[TBL] [Abstract][Full Text] [Related]
20. Antibody-Drug Conjugates: A Review of Approved Drugs and Their Clinical Level of Evidence.
Gogia P; Ashraf H; Bhasin S; Xu Y
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
